InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Sailer Carl, Director. Officer active across 1 companies, notably Acurx Pharmaceuticals, Inc.. Cumulatively, 4 disclosures have been recorded. Total volume traded: €170k. The latest transaction was filed on 23 November 2021 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations4 total
€22,2195,161 shares@ €4.305226.1% of flow
Common Stock
SEC:0001104659-21-143551·
Ideal exit: 20 Aug 2022 (T+270)
€22,2195,161 shares@ €4.30520.38% mcap13.0% of flow
Common Stock
SEC:0001104659-21-143551:0·
Ideal exit: 20 Aug 2022 (T+270)
€63,01512,500 shares@ €5.041273.9% of flow
Common Stock
SEC:0001104659-21-114674·
Ideal exit: 26 Mar 2022 (T+270)
€63,01512,500 shares@ €5.04121.08% mcap37.0% of flow
Common Stock
SEC:0001104659-21-114674:0·
Ideal exit: 26 Mar 2022 (T+270)
4 of 4 declarations
About Sailer Carl
Carl Sailer is a Board Member at Acurx Pharmaceuticals, Inc. He plays a key role in overseeing the company's activities and making strategic decisions. Through his experience, he contributes to developing effective governance practices and achieving growth objectives. His commitment to innovation and corporate social responsibility is a valuable asset to the board.
